28.10.2010 • News

DuPont Quarterly Profit Beats Street

DuPont posted a higher-than-expected quarterly profit as sales rose in all six business units and across the globe.

During the third quarter, the company earned $367 million, or 40 cents per share, compared with $409 million, or 45 cents per share, a year earlier.

Analysts on average expected earnings of 34 cents per share, according to Thomson Reuters I/B/E/S.

Revenue rose 14.8% to $7 billion. Analysts expected $6.72 billion.

For 2010, DuPont now expects to earn $3.10 per share, excluding items, up from a previous estimate of $2.90 to $3.05. Analysts were expecting $3.04.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read